Literature DB >> 8243364

Effects of carbamazepine on auditory brainstem response, middle-latency response, and slow cortical potential in epileptic patients.

G Japaridze1, D Kvernadze, T Geladze, Z Kevanishvili.   

Abstract

Auditory brainstem responses, middle-latency responses, and slow cortical potentials (ABRs, MLRs, SCPs) were recorded in 21 epileptic patients before and during treatment with carbamazepine (CBZ). The peak-latencies, interpeak intervals, and amplitudes were estimated and evaluated statistically. CBZ monotherapy resulted in prolongation of peak latencies of ABR waves I, III, and V as well as of interpeak intervals I-III and I-V. A significant increase in the peak-latencies of MLR components Na, Pa, and Nb and of interpeak intervals V-Pa and Na-Nb was also observed along with the systematic NaPa amplitude reduction. CBZ also prolonged the peak-latencies of SCP components P1 and N1. Based on the obtained results, we suggest that CBZ exerts suppressive influences both on modally specific (lemniscal) and modally nonspecific (extralemniscal) auditory structures.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8243364     DOI: 10.1111/j.1528-1157.1993.tb02141.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  5 in total

Review 1.  Brain stem evoked potentials in childhood neurological diseases.

Authors:  R Kalmanchey
Journal:  Indian J Pediatr       Date:  1997 Sep-Oct       Impact factor: 1.967

2.  Effects of antiepileptic drugs on cortical excitability in humans: A TMS-EMG and TMS-EEG study.

Authors:  Ghazaleh Darmani; Til O Bergmann; Carl Zipser; David Baur; Florian Müller-Dahlhaus; Ulf Ziemann
Journal:  Hum Brain Mapp       Date:  2018-12-13       Impact factor: 5.038

3.  Effects of carbamazepine and valproate on brainstem auditory evoked potentials in epileptic children.

Authors:  A Yuksel; D Senocak; D Sozuer; G Keskin; A Dirican; A Cenani; E Yalcin
Journal:  Childs Nerv Syst       Date:  1995-08       Impact factor: 1.475

4.  Reversible bilateral sensori-neural hearing loss due to olanzapine in a male suffering from bipolar affective disorder.

Authors:  Sumit Kumar Gupta; Bansal Shwetank
Journal:  Indian J Pharmacol       Date:  2014 Jul-Aug       Impact factor: 1.200

5.  TMS as a pharmacodynamic indicator of cortical activity of a novel anti-epileptic drug, XEN1101.

Authors:  Isabella Premoli; Pierre G Rossini; Paul Y Goldberg; Kristina Posadas; Louise Green; Noah Yogo; Simon Pimstone; Eugenio Abela; Gregory N Beatch; Mark P Richardson
Journal:  Ann Clin Transl Neurol       Date:  2019-09-30       Impact factor: 4.511

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.